Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

The evaluation of lung involvement and functional capacities in patients diagnosed with primary Sjogren's syndrome.

Tytuł :
The evaluation of lung involvement and functional capacities in patients diagnosed with primary Sjogren's syndrome.
Autorzy :
Sahin Ozdemirel T; Department of Pulmonology, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Ozdemirel AE; Department of Rheumatology, Gaziler Physical Therapy and Rehabilitation Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Akinci Ozyurek B; Department of Pulmonology, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Yenibertiz D; Department of Pulmonology, Kecioren Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Erdogan Y; Department of Pulmonology, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Oct; Vol. 75 (10), pp. e14635. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Publication: 2003- : Oxford, U.K. : Wiley
Original Publication: Esher [England] ; Bronxville, N.Y. : Medicom International, c1997-
MeSH Terms :
Sjogren's Syndrome*/diagnosis
Female ; Humans ; Lung/diagnostic imaging ; Male ; Respiratory Function Tests ; Retrospective Studies ; Tomography, X-Ray Computed
References :
Wang Y, Hou Z, Qiu M, Ye Q. Risk factors for primary Sjögren syndrome-associated interstitial lung disease. J Thorac Dis. 2018;10(4):2108-2117.
Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med. 1998;19(4):687-699.
Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren's syndrome. Dtsch Arztebl Int. 2017;114(20):354-361.
Flament T, Bigot A, Chaigne B, et al. Pulmonary manifestations of Sjögren's syndrome. Eur Respir Rev. 2016;25(140):110-123.
Jaeger VK, Wirz EG, Allanore Y, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS One. 2016;11(10):e0163894.
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558.
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35-45.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968.
Kotloff RM, Tino G, Palevsky HI, et al. Comparison of short-term functional outcomes following unilateral and bilateral lung volume reduction surgery. Chest. 1998;113(4):890-895.
Chen MH, Chou HP, Lai CC, et al. Lung involvement in primary Sjögren's syndrome: correlation between high-resolution computed tomography score and mortality. J Chin Med Assoc. 2014;77(2):75-82.
Hatron PY, Tillie-Leblond I, Launay D, Hachulla E, Fauchais AL, Wallaert B. Pulmonary manifestations of Sjögren's syndrome. Presse Med. 2011;40(1 Pt 2):e49-e64.
Egashira R, Kondo T, Hirai T, et al. CT findings of thoracic manifestations of primary Sjögren syndrome: radiologic-pathologic correlation. Radiographics. 2013;33:1933-1949.
Dong X, Zhou J, Guo X, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981-2988.
Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjogren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569.
Reina D, Roig Vilaseca D, Torrente-Segarra Vranera M, et al. Sjögren's syndrome-associated interstitial lung disease: a multicenter study. Reumatol Clin. 2016;12(4):201-205.
Palm O, Garen T, Berge Enger T, et al. Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data. Rheumatology. 2013;52(1):173-179.
Yazisiz V, Arslan G, Ozbudak IH, et al. Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317-1324.
Enright PL. The six-minute walk test. Respir Care. 2003;48(8):783-785.
Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6 minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168(9):1084-1090.
Hallstrand TS, Boitano LJ, Johnson WC, et al. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J. 2005;25(1):96-103.
Lederer DJ, Arcasoy SM, Wilt JS, et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(6):659-664.
Kampolis CF, Fragkioudaki S, Mavragani CP, et al. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome. Clin Exp Rheumatol. 2018;36(Suppl 112): 94-101.
Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004;25(3):549-559.
Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome. Ann Rheum Dis. 2000;59(9):709-712.
Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-638.
Sebastian A, Misterska-Skóra M, Silicki J, Sebastian M, Wiland P. Chest HRCT findings in patients with primary Sjögren's syndrome. Adv Clin Exp Med. 2017;26(7):1101-1106.
Roca F, Domınıque S, Schmıdt J, et al. Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev. 2017;16:48-54.
Entry Date(s) :
Date Created: 20210726 Date Completed: 20210921 Latest Revision: 20210921
Update Code :
20210923
DOI :
10.1111/ijcp.14635
PMID :
34310801
Czasopismo naukowe
Introduction: Sjögren syndrome (SS) is a chronic, systemic, inflammatory disease characterised with lymphocytic infiltration of the exocrine glands, frequently manifested by dryness in the region affected. Although the most common extraglandular involvement in SS is pulmonary involvement. Early diagnosis and treatment is considered to be important. It was aimed to evaluate the frequency of early lung involvement, high resolution computed tomography (HRCT) findings and data of pulmonary function test (PFT) in SS in this study.
Materials and Methods: Thirty-five patients diagnosed with SS and referred by the Department of Rheumatology to determine potential lung involvement to the eighth chest diseases outpatient clinic of our hospital between September 2015 and December 2018 were included in this study. Respiratory signs, demographic features, length of disease and treatment regimens, PFT, data of 6-minute walk test and findings of HRCT of the patients were retrospectively obtained from hospital information system and patient files.
Results: The mean age of the patients was 54.4 ± 9.2. The majority of the patients were women (94.3%). When the HRCT findings were evaluated, 28 (80%) patients had CT findings, while 7 (20%) patients had no CT findings. The most common HRCT findings found in patients were peribronchial thickening (48.6%), ground glass appearance (28.6%) and prominence in interstitial scars.
Conclusion: We think that the evaluation of HRCT and PFTs in patients diagnosed with SS for assessing early pulmonary involvement will be guiding in terms of follow-up and treatment.
(© 2021 John Wiley & Sons Ltd.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies